Company / Shareholders' Equity
Cytosorbents Corp Shareholders' Equity History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$16.9M
FY2018
5-year range
$4.0M / $16.9M
FY2014-FY2018
Trend
+65.0%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $4M to $17M over the past 2 years.
Based on SEC 10-K filings.
$17M in FY2018 with a 3-year CAGR of +19.8%.
Improved from $4M to $17M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +19.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +19.8%, indicating consistent growth.
- In FY2018, shareholders' equity increased 65.0% year-over-year.
- Lowest shareholders' equity in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -4.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $16.9M | +65.0% |
| FY2017 | $10.3M | +159.0% |
| FY2016 | $4.0M | -59.8% |
| FY2015 | $9.8M | +41.8% |
| FY2014 | $6.9M | +159.7% |
| FY2013 | -$11.6M | +0.0% |
| FY2012 | -$11.6M | -15.2% |
| FY2011 | -$10.1M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026